Results 101 to 110 of about 8,231 (262)

Laparoscopic removal of an eroding Mirena coil through the sigmoid colon [PDF]

, 2014
Letter to the ...
Cheung, VYT
core   +1 more source

Zinc as a non-hormonal contraceptive: a better alternative to the copper intrauterine device (IUD) [PDF]

, 2022
Kirsten Norma Shankie-williams, Laura A. Lindsay, Christopher R. Murphy, Samson N. Dowland   +3 more
openalex   +1 more source

Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration [PDF]

, 2017
The subdermal contraceptive implant, and the 52mg levonorgestrel intrauterine device (IUD) are currently FDA-approved for three and five years of use respectively. Limited available data has suggested both of these methods are effective beyond that time.
McNicholas, Colleen, Peipert, Jeffrey F., Swor, Erin, Wan, Leping Wan   +3 more
core   +1 more source

One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial. [PDF]

Am J Obstet Gynecol, 2023
Kaiser JE, Turok DK, Gero A, Gawron LM, Simmons RG, Sanders JN.   +5 more
europepmc   +1 more source

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population-based study. [PDF]

Int J Gynaecol Obstet, 2023
Roland N, Baricault B, Dray-Spira R, Weill A, Duranteau L, Zureik M.   +5 more
europepmc   +1 more source

Contraception with levonorgestrel-releasing intrauterine system versus copper intrauterine device: a meta-analysis of randomized controlled trialsResearch in context

EClinicalMedicine
Summary: Background: Globally, approximately 19.4% of women of reproductive age use intrauterine contraception, encompassing both copper intrauterine devices (Cu-IUDs) and levonorgestrel intrauterine devices (LNG-IUDs).
Pan Liu, Jiahao Meng, Yilin Xiong, Yumei Wu, Yifan Xiao, Shuguang Gao   +5 more
doaj   +1 more source

Comparing the Effect of Mefenamic Acid and Vitex Agnus on Intrauterine Device Induced Bleeding [PDF]

, 2013
Introduction: Increased bleeding is the most common cause of intrauterine device (IUD) removal. The use of alternative therapies to treat bleeding has increased due to the complications of medications.
Mahnaz Shahnazi, Parisa Yavarikia, Razieh Lutfi, Samira Hadavand Mirzaie, Yousef Javadzadeh   +4 more
core   +1 more source

FIGO postpartum intrauterine device initiative: Complication rates across six countries. [PDF]

, 2018
OBJECTIVE: To record and analyze complication rates following postpartum intrauterine device (PPIUD) insertion in 48 hospitals in six countries: Sri Lanka, India, Nepal, Bangladesh, Tanzania, and Kenya.
Arulkumaran, S, Divakar, H, Fatima, P, Machiyama, K, Makins, A, Munganyizi, P, Odongo, E, Perera, G, Sethi, M, Taghinejadi, N, Thapa, K   +10 more
core   +2 more sources

Continuation rates of two different-sized copper intrauterine devices among nulliparous women: Interim 12-month results of a single-blind, randomised, multicentre trial. [PDF]

EClinicalMedicine, 2022
Hubacher D, Schreiber CA, Turok DK, Jensen JT, Creinin MD, Nanda K, White KO, Dayananda I, Teal SB, Chen PL, Chen BA, Goldberg AB, Kerns JL, Dart C, Nelson AL, Thomas MA, Archer DF, Brown JE, Castaño PM, Burke AE, Kaneshiro B, Blithe DL.   +21 more
europepmc   +1 more source

Comparison of the Effects of Copper T and Levonorgestrel IUD on Proteoglycan Composition of Cervical Mucus

Gynecology Obstetrics & Reproductive Medicine, 2014
OBJECTIVE: The aim of this study was to determine the effects of Copper T and Levonorgestrel IUD (LNG-IUD) on the proteoglycan composition of cervical mucus.
Yeşim Bayoğlu Tekin, Emine Seda Güvendağ Güven, Zihni Açar Yazıcı, Aynur Kırbaş, Figen Kır Şahin   +4 more
doaj